2023
High prevalence of low high‐density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome?
Kisitu G, Shabanova V, Naiga F, Nakagwa M, Kekitiinwa A, Elyanu P, Paintsil E. High prevalence of low high‐density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome? HIV Medicine 2023, 25: 262-275. PMID: 37879630, DOI: 10.1111/hiv.13570.Peer-Reviewed Original ResearchInternational Diabetes FederationLow high-density lipoprotein cholesterolHigh-density lipoprotein cholesterolPrevalence of MetSInsulin resistanceLipoprotein cholesterolMetabolic syndromeAdult Treatment Panel criteriaHomeostatic model assessment indexCross-sectional pilot studyFrequency of MetSModel assessment indexHOMA-IR indexOlder age groupsAge-dependent prevalenceAssociated health problemsATPIII criteriaCentral obesityBlood pressureDiabetes FederationPrimary outcomeClinical centersLifetime riskPanel criteriaHigh prevalence
2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 JACC State-of-the-Art Review
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GYH, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 JACC State-of-the-Art Review. Journal Of The American College Of Cardiology 2021, 78: 1635-1654. PMID: 34649702, PMCID: PMC8504484, DOI: 10.1016/j.jacc.2021.08.021.Peer-Reviewed Original ResearchConceptsLipid-modulating agentsEndothelial activationLow high-density lipoprotein cholesterolCOVID-19High-density lipoprotein cholesterolLipid modulating agentsHigh triglyceride levelsMultiorgan manifestationsStatin trialsLipoprotein cholesterolSystemic inflammationTriglyceride levelsJACC StateWorse outcomesInflammatory responsePatient managementRCTsCoronavirus diseaseViral entrySystematic searchLipid raft disruptionTrialsPatientsRaft disruptionPreventionAllostatic Load Effects on Cortical and Cognitive Deficits in Essentially Normotensive, Normoweight Patients with Schizophrenia
Zhou Y, Huang J, Zhang P, Tong J, Fan F, Gou M, Cui Y, Luo X, Tan S, Wang Z, Feng W, Yang F, Tian B, Tian L, Savransky A, Hare S, Ryan MC, Goldwaser E, Chiappelli J, Chen S, Kochunov P, Kvarta M, Tan Y, Hong LE. Allostatic Load Effects on Cortical and Cognitive Deficits in Essentially Normotensive, Normoweight Patients with Schizophrenia. Schizophrenia Bulletin 2021, 47: 1048-1057. PMID: 33501486, PMCID: PMC8266595, DOI: 10.1093/schbul/sbaa196.Peer-Reviewed Original ResearchConceptsHigher allostatic loadCognitive deficitsCortical thicknessCortical thinningAllostatic loadCholesterol levelsSchizophrenia patientsLow high-density lipoprotein cholesterolHypersensitive C-reactive proteinHigh-density lipoprotein cholesterolLower total cholesterol levelsDiastolic blood pressureTotal cholesterol levelsC-reactive proteinWaist-hip ratioLeft superior frontal gyrusHigh cholesterol levelsMean cortical thicknessHigher heart rateSuperior frontal gyrusEarly intervention strategiesGray matter integrityNormoweight patientsLipoprotein cholesterolBlood pressure
2020
Dyslipidemia in pediatric CKD patients: results from KNOW-PedCKD (KoreaN cohort study for Outcomes in patients With Pediatric CKD)
Baek H, Kim S, Kang H, Choi H, Cheong H, Ha I, Han K, Cho H, Shin J, Park Y, Lee J, Ahn Y, Park E, Cho M. Dyslipidemia in pediatric CKD patients: results from KNOW-PedCKD (KoreaN cohort study for Outcomes in patients With Pediatric CKD). Pediatric Nephrology 2020, 35: 1455-1461. PMID: 32232640, DOI: 10.1007/s00467-020-04545-z.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseNephrotic range proteinuriaPrevalence of dyslipidemiaRisk factorsD deficiencyCardiovascular diseaseChronic kidney disease aged <Lipoprotein cholesterolRisk factors associated with dyslipidemiaAssociated with low high-density lipoprotein cholesterolResultsThe prevalence of dyslipidemiaLow high-density lipoprotein cholesterolFactors associated with dyslipidemiaBody mass index z-scoreHigh low-density lipoprotein cholesterolMultivariate logistic regression analysisPediatric CKD patientsChronic kidney disease progressionLow-density lipoprotein cholesterolHigh-density lipoprotein cholesterolAsian pediatric patientsSusceptibility to cardiovascular diseaseLogistic regression analysisCohort cross-sectionallyLipid abnormalities
2010
High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease
Taddei TH, Dziura J, Chen S, Yang R, Hyogo H, Sullards C, Cohen DE, Pastores G, Mistry PK. High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease. Journal Of Inherited Metabolic Disease 2010, 33: 291-300. PMID: 20354791, PMCID: PMC3008397, DOI: 10.1007/s10545-010-9070-1.Peer-Reviewed Original ResearchConceptsPrevalence of gallstonesType 1 Gaucher diseaseBody mass indexBile lipid analysisGaucher diseaseLipoprotein cholesterolHigh low-density lipoprotein cholesterolLow high-density lipoprotein cholesterolHigh-density lipoprotein cholesterolLow-density lipoprotein cholesterolMultiple logistic regression analysisType 1 Gaucher's diseaseBile lipid compositionBiliary lipid secretionCholesterol gallstone diseaseLogistic regression analysisMetabolic syndromeGallstone diseaseLDL cholesterolStudy cohortLipoprotein profileMass indexFemale sexBile compositionBiliary lipids
2007
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ, Investigators F. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. The Lancet 2007, 370: 153-160. PMID: 17630038, DOI: 10.1016/s0140-6736(07)61088-5.Peer-Reviewed Original ResearchConceptsIntima-media thicknessMaximum intima-media thicknessCarotid intima-media thicknessDouble-blind trialSystolic blood pressureCombined-treatment groupMixed dyslipidaemiaCholesteryl ester transfer proteinHDL cholesterolLipoprotein cholesterolBlood pressureLDL cholesterolCarotid segmentsHigh low-density lipoprotein cholesterolLow high-density lipoprotein cholesterolMaximum carotid intima-media thicknessHigh-density lipoprotein cholesterolLow-density lipoprotein cholesterolCarotid atherosclerosis progressionDose of treatmentYearly rateEster transfer proteinDose titrationPrimary endpointAtherosclerosis progression
2006
Adiponectin in Childhood and Adolescent Obesity and Its Association with Inflammatory Markers and Components of the Metabolic Syndrome
Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S. Adiponectin in Childhood and Adolescent Obesity and Its Association with Inflammatory Markers and Components of the Metabolic Syndrome. The Journal Of Clinical Endocrinology & Metabolism 2006, 91: 4415-4423. PMID: 16926246, DOI: 10.1210/jc.2006-0733.Peer-Reviewed Original ResearchConceptsC-reactive proteinAdiponectin levelsMetabolic syndromeObese childrenInsulin resistanceChildhood obesityLow high-density lipoprotein cholesterolStandard oral glucose tolerance testBody mass index z-scoreHigh-density lipoprotein cholesterolOral glucose tolerance testHigher CRP levelsChronic inflammatory stateMarkers of inflammationPlasma lipid profileGlucose tolerance testIndex z-scorePotential confounding variablesCRP levelsInflammatory markersLipoprotein ratioHigh triglyceridesLipoprotein cholesterolInflammatory stateProinflammatory cytokines266 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE METABOLIC SYNDROME.
Huang J, Parish R, Yu H, Bass P, Mansi I, Kennen E, Davis T, Carden D. 266 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE METABOLIC SYNDROME. Journal Of Investigative Medicine 2006, 54: s303. DOI: 10.2310/6650.2005.x0008.265.Peer-Reviewed Original ResearchLow-density lipoprotein cholesterolHigh-density lipoprotein cholesterolLow high-density lipoprotein cholesterolMetabolic syndromeLipoprotein cholesterolCoronary artery disease preventionPrevalence of MSDiagnosis of MSPercent of patientsPrevalence of dyslipidemiaNon-HDL cholesterolDensity lipoprotein cholesterolHigher atherogenic potentialCardiovascular morbidityCentral obesityLipid managementElevated BPElevated triglyceridesHigh triglyceridesMS patientsAggressive loweringNCEP criteriaInsulin resistanceLipid therapyPatient population
2005
Racial Disparities in Stroke Risk Factors
Bravata DM, Wells CK, Gulanski B, Kernan WN, Brass LM, Long J, Concato J. Racial Disparities in Stroke Risk Factors. Stroke 2005, 36: 1507-1511. PMID: 15961710, DOI: 10.1161/01.str.0000170991.63594.b6.Peer-Reviewed Original ResearchConceptsStroke risk factorsRisk factorsStroke historyHigh prevalenceLow high-density lipoprotein cholesterolHigher C-reactive proteinHigh-density lipoprotein cholesterolCommunity-dwelling stroke survivorsC-reactive proteinThird National HealthSevere strokeLipoprotein cholesterolMyocardial infarctionNational HealthStroke survivorsNutrition SurveyHigh incidenceUS populationStrokeOlder ageCross-sectional samplePrevalenceRacial disparitiesEthnic differencesAssociation
1996
Employment and Coronary Risk in Women at Midlife: A Longitudinal Analysis
Ickovics J, Morrill A, Meisler A, Rodin J, Bromberger J, Matthews K. Employment and Coronary Risk in Women at Midlife: A Longitudinal Analysis. American Journal Of Epidemiology 1996, 143: 144-150. PMID: 8546115, DOI: 10.1093/oxfordjournals.aje.a008723.Peer-Reviewed Original ResearchConceptsHigh-density lipoprotein cholesterolDensity lipoprotein cholesterolLipoprotein cholesterolHealth behaviorsTotal high-density lipoprotein cholesterolLow high-density lipoprotein cholesterolMenopause-related changesHealth-related variablesCholesterol subfractionsCoronary riskCholesterol levelsCoronary healthLongitudinal assessmentCholesterolStudy periodBaselinePotential mechanismsSignificant decreaseWomenAllegheny CountyLongitudinal analysisEmployment statusHealthDetrimental effectsYears
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply